BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/15/2023 6:05:28 AM | Browse: 145 | Download: 564
 |
Received |
|
2023-02-19 04:09 |
|
Peer-Review Started |
|
2023-02-19 04:11 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-03-22 18:02 |
|
Revised |
|
2023-04-09 06:42 |
|
Second Decision |
|
2023-04-23 03:24 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2023-04-23 08:54 |
|
Articles in Press |
|
2023-04-23 08:54 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-06-08 03:40 |
|
Publish the Manuscript Online |
|
2023-06-15 06:05 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Advanced gastric cancer achieving major pathologic regression after chemoimmunotherapy combined with hypofractionated radiotherapy: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Meng-Long Zhou, Ruo-Ne Xu, Cong Tan, Zhen Zhang and Jue-Feng Wan |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China (General Program) |
81773357 |
|
| Corresponding Author |
Jue-Feng Wan, MD, Assistant Professor, Department of Radiation Oncology, Fudan University Shanghai Cancer Center, No. 270 Dong'an Road, Shanghai 200032, China. wjf62313172@163.com |
| Key Words |
Gastric cancer; Oligometastasis; Immunotherapy; Hypofractionated radiotherapy; Gastrectomy; Case report |
| Core Tip |
This case report describes a patient with unresectable advanced gastric cancer who received comprehensive treatment including chemoimmunotherapy and hypofractionated radiotherapy that was applied to treat the primary lesion; satisfactory efficacy was achieved. The combination of radiotherapy and immunotherapy is worthy of further exploration, and the dose division of radiotherapy is an important factor. Hypofractionated radiotherapy, compared to conventional fractionated radiotherapy, may better coordinate with immunotherapy. |
| Publish Date |
2023-06-15 06:05 |
| Citation |
Zhou ML, Xu RN, Tan C, Zhang Z, Wan JF. Advanced gastric cancer achieving major pathologic regression after chemoimmunotherapy combined with hypofractionated radiotherapy: A case report. World J Gastrointest Oncol 2023; 15(6): 1096-1104 |
| URL |
https://www.wjgnet.com/1948-5204/full/v15/i6/1096.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v15.i6.1096 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
